2.1500
-0.0100
(-0.46%)
At close: 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,783.0000
-23,325.0000
-45,568.0000
-35,941.0000
-25,980.0000
Investing Cash Flow
-199.0000
-932.0000
-4,340.0000
-13,961.0000
-11,748.0000
Financing Cash Flow
9,562.0000
12,186.0000
35,806.0000
78,364.0000
22,799.0000
End Cash Position
5,063.0000
11,132.0000
23,203.0000
37,305.0000
8,843.0000
Interest Paid Supplemental Data
17.0000
--
24.0000
114.0000
209.0000
Capital Expenditure
-566.0000
-281.0000
-4,340.0000
-2,247.0000
-1,227.0000
Issuance of Capital Stock
15,825.0000
13,848.0000
37,718.0000
77,987.0000
20,805.0000
Issuance of Debt
--
--
--
--
1,141.0000
Repayment of Debt
-149.0000
-117.0000
-1,429.0000
-1,534.0000
-446.0000
Repurchase of Capital Stock
-5,389.0000
-1,118.0000
--
-239.0000
-14.0000
Free Cash Flow
-20,349.0000
-23,606.0000
-49,908.0000
-38,188.0000
-27,207.0000
12/31/2020 - 12/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ISPC iSpecimen Inc.
2.6400
-1.49%
GTG.AX Genetic Technologies Limited
0.0390
0.00%
BIOCQ Biocept, Inc.
0.0001
0.00%
PRPO Precipio, Inc.
6.06
+3.24%
BDSX Biodesix, Inc.
1.1300
-8.87%
PSNL Personalis, Inc.
5.13
-4.11%
QGEN Qiagen N.V.
45.57
-0.93%
BIAF bioAffinity Technologies, Inc.
0.7575
+0.37%
MYGN Myriad Genetics, Inc.
13.68
-4.20%
NDRA ENDRA Life Sciences Inc.
5.92
+3.32%